Investigation of bystander effects of hypoxia activated prodrugs using three dimensional cell cultures (Abstract #4513)

Show simple item record

dc.contributor.author Hong, Cho en
dc.contributor.author Bogle, Miles en
dc.contributor.author Wilson, William en
dc.contributor.author Hicks, Kevin en
dc.date.accessioned 2018-10-22T19:54:07Z en
dc.date.issued 2017-04-04 en
dc.identifier.uri http://hdl.handle.net/2292/43035 en
dc.description.abstract Background: Hypoxia in solid tumors acts as the major barrier to anticancer therapies and promotes tumor progression. Hypoxia-activated prodrugs (HAPs) are designed to not only eliminate these resistant cells, but also to exploit hypoxia as a basis of tumor selectivity. A key concept in exploiting hypoxia with HAPs is that active drug metabolite should be able to diffuse from hypoxic zones to maximize effect in surrounding aerobic tumor tissue. There is some evidence that these ’bystander effects’ contribute to the antitumor activity of HAPs, but currently there is a lack of robust methods for their detection. Objectives: To investigate bystander effects from HAPs in a novel spheroid co-culture system using PR104A which releases a diffusible DNA crosslinking mustard and the tirapazamine analogue SN30000 which is converted to a short lived radical that is not expected to diffuse out of cells. Methods: A new method for measuring the bystander effect with multicellular spheroids under hypoxic conditions was developed using co-cultures of HCT116 colon cancer cells with high metabolic capacity for HAP metabolism (activators, transfected to overexpress cytochrome P450 reductase [POR]) and cells that cannot activate HAPs effıciently (targets, with POR knocked out by zinc fınger nuclease gene targeting) along with differential antibiotic resistance and fluorescent protein markers to enable their quantitation in mixed cultures. Sensitivity of activators and targets to PR104A and SN30000 was determined in spheroid co-cultures by dissociation and clonogenic cell survival assay. Results were compared to output of a novel agent-based mathematical model (ABM) of spheroid co-cultures. Results: In monolayer cultures, activator cells showed markedly higher sensitivity to the HAPs than did targets. Tagging of activators and targets with fluorescent proteins allowed visualization of their spatial distribution in spheroid cocultures. When spheroids were treated with PR104A, killing of targets markedly increased with increasing proportion of activators, confırming a bystander effect. However, increasing proportions of activators reduced cell killing of targets after SN30000 treatment, suggesting that rapid metabolism by activators inhibits its penetration, which was confırmed by flux experiments in multicellular layer co-cultures. ABM simulations of cell killing by PR104A and SN30000 in spheroids using our published transport parameters agreed with experimental results indicating diffusion of active metabolites of PR104A but not SN30000. Discussion: Using this novel spheroid co-culture model, a bystander effect of PR104A was demonstrated while SN30000 showed no bystander effect. This is the most direct demonstration of a hypoxic bystander effect for PR104A to date, and demonstrates the utility of the novel spheroid ABM in simulating active metabolite diffusion in 3D co-cultures. en
dc.relation.ispartof Annual Conference of the American Association For Cancer Research en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Investigation of bystander effects of hypoxia activated prodrugs using three dimensional cell cultures (Abstract #4513) en
dc.type Conference Item en
dc.rights.holder Copyright: The author en
pubs.author-url http://www.aacr.org/Documents/AACR2017_Proceedings.pdf en
pubs.finish-date 2017-04-04 en
pubs.start-date 2017-04-01 en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.subtype Abstract en
pubs.elements-id 684520 en
pubs.org-id Bioengineering Institute en
pubs.org-id ABI Associates en
pubs.org-id Medical and Health Sciences en
pubs.org-id Medical Sciences en
pubs.org-id Auckland Cancer Research en
pubs.org-id Science en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.record-created-at-source-date 2017-10-06 en


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics